Revised SPC: Dyzantil (sodium valproate/valproic acid) prolonged-release tablets

SPC updated to note co-administration of sodium valproate with metamizole (inducer of metabolising enzymes; not available in UK) may cause reduction in plasma concentrations of sodium valproate with potential decrease in efficacy; caution therefore advised when co-administered.

Source:

electronic Medicines compendium